302 related articles for article (PubMed ID: 29141625)
1. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
[TBL] [Abstract][Full Text] [Related]
2. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
Vinall RL; Kent MS; deVere White RW
Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
[TBL] [Abstract][Full Text] [Related]
3. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T
Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385
[TBL] [Abstract][Full Text] [Related]
5. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.
Henry CJ; Tyler JW; McEntee MC; Stokol T; Rogers KS; Chun R; Garrett LD; McCaw DL; Higginbotham ML; Flessland KA; Stokes PK
Am J Vet Res; 2003 Aug; 64(8):1017-20. PubMed ID: 12926595
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor expression in canine transitional cell carcinoma.
Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T
J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs.
Sotirakopoulos AJ; Armstrong PJ; Heath L; Madrill NJ; McNiel EA
J Vet Intern Med; 2010; 24(6):1445-51. PubMed ID: 21039871
[TBL] [Abstract][Full Text] [Related]
9. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
Walters L; Martin O; Price J; Sula MM
Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma.
Hamlin AN; Chadwick LE; Fox-Alvarez SA; Hostnik ET
Vet Radiol Ultrasound; 2019 Sep; 60(5):552-559. PubMed ID: 31144408
[TBL] [Abstract][Full Text] [Related]
11. Expression of microRNAs in the urine of patients with bladder cancer.
Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of the BRAF variant V595E in urine samples, smears and biopsies from canine transitional cell carcinoma].
Aupperle-Lellbach H; Grassinger J; Hohloch C; Kehl A; Pantke P
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):289-295. PubMed ID: 30541168
[TBL] [Abstract][Full Text] [Related]
13. NMR-based metabolomics study of canine bladder cancer.
Zhang J; Wei S; Liu L; Nagana Gowda GA; Bonney P; Stewart J; Knapp DW; Raftery D
Biochim Biophys Acta; 2012 Nov; 1822(11):1807-14. PubMed ID: 22967815
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
[TBL] [Abstract][Full Text] [Related]
15. Management of transitional cell carcinoma of the urinary bladder in dogs: a review.
Fulkerson CM; Knapp DW
Vet J; 2015 Aug; 205(2):217-25. PubMed ID: 25747698
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder.
Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A
Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650
[TBL] [Abstract][Full Text] [Related]
17. Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma.
Finotello R; Schiavo L; Ressel L; Frohmader A; Silvestrini P; Verin R
J Comp Pathol; 2019 Jul; 170():1-9. PubMed ID: 31375151
[TBL] [Abstract][Full Text] [Related]
18. Measurement of urinary canine S100A8/A9 and S100A12 concentrations as candidate biomarkers of lower urinary tract neoplasia in dogs.
Heilmann RM; Wright ZM; Lanerie DJ; Suchodolski JS; Steiner JM
J Vet Diagn Invest; 2014 Jan; 26(1):104-12. PubMed ID: 24398905
[TBL] [Abstract][Full Text] [Related]
19. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.
Knapp DW; Ramos-Vara JA; Moore GE; Dhawan D; Bonney PL; Young KE
ILAR J; 2014; 55(1):100-18. PubMed ID: 24936033
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder.
Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T
Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
